Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Other Stress Responses in Bacteria

Other Stress Responses in Bacteria

Bacteria have global regulatory systems that control several types of stress mechanisms. These include Pho regulon and the heat shock response, which are essential systems for environmental adaptation, such as nutrient limitation and proteotoxic stress. The Pho regulon and the heat shock response exemplify bacterial resilience, enabling rapid adaptation to fluctuating environmental conditions.Pho RegulonBacteria require phosphorus for essential cellular processes, including nucleic acid...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Echinococcus granulosus</i> antigen B acts as an LPS-scavenging lipoprotein <i>in vitro,</i> preventing TLR4-mediated activation of dendritic cells.

Infection and immunity·2025

Same author

Context-dependent effects of progesterone 4-pregnene metabolites on apoptosis and proliferation in ovarian cancer cell lines IGROV-1 and SK-OV-3.

The Journal of steroid biochemistry and molecular biology·2025

Same author

Galgo: a bi-objective evolutionary meta-heuristic identifies robust transcriptomic classifiers associated with patient outcome across multiple cancer types.

Bioinformatics (Oxford, England)·2020

Same author

Hypothyroidism reduces mammary tumor progression via Β-catenin-activated intrinsic apoptotic pathway in rats.

Histochemistry and cell biology·2017

Same author

Chemokine response induced by Chlamydia trachomatis in prostate derived CD45+ and CD45- cells.

Reproduction (Cambridge, England)·2011

Same author

Estrogen receptors and cell proliferation in breast cancer.

Trends in endocrinology and metabolism: TEM·2008

Search research articles

Related Experiment Video

Updated: May 20, 2026

Intracellular Refolding Assay

Intracellular Refolding Assay

Published on: January 24, 2012

Heat shock proteins (HSPs) based anti-cancer vaccines.

D R Ciocca¹, N Cayado-Gutierrez, M Maccioni

¹Oncology Laboratory, IMBECU, CCT Mendoza, Ruiz Leal s/n, Parque Gral. San Martin, C.C. 855, Mendoza 5500, Argentina. dciocca@mendoza-conicet.gob.ar

Current Molecular Medicine

|July 19, 2012

Summary

Heat Shock Proteins (HSPs) show promise as anticancer vaccine adjuvants by presenting tumor antigens to T cells. Clinical trials demonstrate potential, especially in melanoma and renal clear cell cancer.

More Related Videos

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Related Experiment Videos

Last Updated: May 20, 2026

Intracellular Refolding Assay

Intracellular Refolding Assay

Published on: January 24, 2012

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Area of Science:

Immunology
Oncology
Vaccinology

Background:

Heat Shock Proteins (HSPs) play a role in antigen presentation and immune response regulation.
HSPs are recognized for their potential as anticancer vaccine adjuvants.
Their precise mechanisms in innate and adaptive immunity are under active investigation.

Purpose of the Study:

To review the role of HSPs in antigen presentation and their application as anticancer vaccine adjuvants.
To summarize various delivery systems and administration routes for HSP-based vaccines.
To highlight clinical trial outcomes and ongoing research in cancer immunotherapy.

Main Methods:

Review of existing literature on HSPs in cancer immunology.
Analysis of preclinical models for HSP-based vaccine efficacy and safety.
Examination of clinical trial data for HSP-based cancer vaccines.

Main Results:

HSPs bind and present tumor antigens, activating anti-tumor CD8+ and CD4+ T cells.
HSP-based vaccines utilize diverse delivery systems and routes with minimal toxicity in preclinical models.
Clinical studies show promising results, particularly for HSP-peptide complexes in melanoma and renal clear cell cancer.

Conclusions:

HSPs are effective adjuvants in anticancer vaccines, inducing specific and non-specific cellular immune responses.
Antibody generation following vaccination contributes significantly to the antitumoral response.
Clinical trials are ongoing, with notable success in specific cancer types, suggesting a promising future for HSP-based cancer immunotherapy.